Informed-money record
Disclosed informed-money activity on this name over the last 12 months — corporate insiders, institutions, and members of Congress, from public-domain SEC and congressional filings. A dated factual record with receipts; interpretation is yours.
Bullish filings
8
Bearish filings
14
Named actors
21
Disclosed $ (bull / bear)
$85.3M / $1.2M
| Date | Who | What | Disclosed $ | Receipt |
|---|---|---|---|---|
| 2026-07-16 | Director Fairmount Funds Management LLC | bought | $12.4M | SEC ↗ |
| 2026-06-22 | Chief Executive Officer Brumm Joshua T | sold | $761K | SEC ↗ |
| 2026-06-22 | President and COO McNeill Jonathan | sold | $370K | SEC ↗ |
| 2026-06-22 | Chief Medical Officer Im Ellie Eunkyung | sold | $22K | SEC ↗ |
| 2026-06-22 | See Remarks Bispham Barbara Harlin | sold | $22K | SEC ↗ |
Want the read, not just the record?
Members see how notable each move is, whether the actor's track record validates, cross-source convergence, and alerts on this name.
Create a free account →Events dated by when the activity occurred (a trade's transaction date; a notice, stake, or announcement at its filing date); the linked filing is the authoritative record. Directional public-domain disclosures only. Descriptive, not investment advice. Methodology · Today's notable signals
| 2026-06-22 | Chief Financial Officer Scalzo Richard William | sold | $20K | SEC ↗ |
| 2026-06-22 | Chief Scientific Officer Pinkas Jan | sold | $23K | SEC ↗ |
| 2026-06-22 | See Remarks Lynch Ryan | sold | $8K | SEC ↗ |
| 2026-05-15 | 5%+ holder (13G) BALYASNY ASSET MANAGEMENT L.P. | disclosed a passive stake (13G) | — | SEC ↗ |
| 2026-02-25 | Chief Operating Officer and President Jonathan McNeill | adopted a selling plan | — | SEC ↗ |
| 2026-02-25 | General Counsel and Corporate Secretary Barbara Bispham Hale | adopted a selling plan | — | SEC ↗ |
| 2026-02-25 | Chief Executive Officer and member of the Company’s Board of Directors Joshua Brumm | adopted a selling plan | — | SEC ↗ |
| 2026-02-25 | Treasurer, Senior Vice President of Finance and Chief Accounting Officer Ryan Lynch | adopted a selling plan | — | SEC ↗ |
| 2026-02-25 | Chief Medical Officer Ellie Im | adopted a selling plan | — | SEC ↗ |
| 2026-02-25 | Chief Financial Officer Richard Scalzo | adopted a selling plan | — | SEC ↗ |
| 2026-02-25 | Chief Scientific Officer Jan Pinkas | adopted a selling plan | — | SEC ↗ |
| 2025-12-11 | 5%+ holder (13G) ForGrowth III PA B.V. | disclosed a passive stake (13G) | — | SEC ↗ |
| 2025-12-04 | Director Fairmount Healthcare Fund II L.P. | bought | $18.2M | SEC ↗ |
| 2025-12-04 | Director Kiselak Tomas | bought | $18.2M | SEC ↗ |
| 2025-12-04 | Director Fairmount Funds Management LLC | bought | $18.2M | SEC ↗ |
| 2025-12-04 | Director Harwin Peter Evan | bought | $18.2M | SEC ↗ |
| 2025-10-09 | 5%+ holder (13G) TANG CAPITAL MANAGEMENT LLC | disclosed a passive stake (13G) | — | SEC ↗ |